Phylogenetic classification of human papillomavirus genotypes in high-grade cervical intraepithelial neoplasia in women from a densely populated Brazilian urban region

Sao Paulo Medical Journal

Volumn 127, Issue 3, 2009, Pages 122-127

  Pitta, Denise Rocha ^a   Sarian, Luis Otávio ^a   Campos, Elisabete Aparecida ^a   Rabelo Santos, Sílvia Helena ^a,b   Syrjänen, Kari ^a,c   Derchain, Sophie Françoise ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cancer; Cervical intraepithelial neoplasia; Genotype; Human papillomavirus 11; Human papillomavirus 16; Human papillomavirus 18; Human papillomavirus 6; Polymerase chain reaction

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CANCER GRADING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 58; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PAPILLOMA VIRUS; PHYLOGENY; POPULATION DENSITY; URBAN AREA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CLASSIFICATION; VIRUS GENE; VIRUS INFECTION; VIRUS TYPING; WART VIRUS;

ADOLESCENT; ADULT; AGED; BRAZIL; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA, VIRAL; EPIDEMIOLOGIC METHODS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 70849124146     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802009000300003     Document Type: Article

References (27)

1. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19 (Pubitemid 29406813)
2. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003;89(1): 101-105 (Pubitemid 36897943)
3. Muñoz N, Bosch FX, de Sanjosé S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348(6):518-527 (Pubitemid 36159887)
4. Moscicki AB, Schiffman M, Kjaer S, Villa LL. Chapter 5: Updating the natural history of HPV and anogenital cancer. Vaccine. 2006;24 Suppl 3:S3/S42-51.
5. Baak JP, Kruse AJ, Robboy SJ, Janssen EA, van Diermen B, Skaland I. Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol. 2006;59(10):1017-1028 (Pubitemid 44570323)
6. Syrjänen KJ, Syrjänen SM. Papillomavirus infections in human pathology. England: John Wiley & Sons Ltd; 2000.
7. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol. 2006;208(2):152-164 (Pubitemid 43126109)
8. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007;121(3):621-632 (Pubitemid 46986496)
9. Zuna RE, Allen RA, Moore WE, Lu Y, Mattu R, Dunn ST. Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type. Mod Pathol. 2007;20(2):167-174 (Pubitemid 46422170)
10. Zuna RE, Allen RA, Moore WE, Mattu R, Dunn ST. Comparison of human papillomavirus genotypes in high-grade squamous intraepithelial lesions and invasive cervical carcinoma: evidence or differences in biologic potential of precursor lesions. Mod Pathol. 2004;17(11):1314-1322
11. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17-27.
12. Liaw KL, Hildesheim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infec Dis. 2001;183(1):8-15. (Pubitemid 32043036)
13. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis. 2001;184(12):1508- 1517
14. Weissenborn SJ, Funke AM, Hellmich M, et al. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol. 2003;41(6):2763-2767
15. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer. 2007;7(1):11-22. (Pubitemid 46020844)
16. Trottier H, Mahmud S, Costa MC, et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1274-1280 (Pubitemid 44125281)
17. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. Histological typing of female genital tract tumors. (International histological classification of tumors). 2nd ed. Berlin: Springer-Verlag; 1994.
18. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38(1):357-361
19. Castle PE, Sadorra M, Garcia F, Holladay EB, Kornegay J. Pilot study of a commercialized human papillomavirus (HPV) genotyping assay: comparison of HPV risk group to cytology and histology. J Clin Microbiol. 2006;44(11):3915-3917 (Pubitemid 44737228)
20. Gargiulo F, De Francesco MA, Schreiber C, et al. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res. 2007;125(2):176-182 (Pubitemid 46613818)
21. Giuliani L, Coletti A, Syrjänen K, Favalli C, Ciotti M. Comparison of DNA sequencing and Roche Linear array in human papillomavirus (HPV) genotyping. Anticancer Res. 2006;26(5B):3939-3941 (Pubitemid 44701481)
22. Woo YL, Damay I, Stanley M, Crawford R, Sterling J. The use of HPV Linear Array Assay for multiple HPV typing on archival frozen tissue and DNA specimens. J Virol Methods. 2007;142(1-2):226-230 (Pubitemid 46590423)
23. Coutlée F, Rouleau D, Petignat P, et al. Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol. 2006;44(6):1998-2006. (Pubitemid 43902145)
24. Meijer CJ, Snijders PJ, Castle PE. Clinical utility of HPV genotyping. Gynecol Oncol. 2006;103(1):12-17
25. Prétet JL, Jacquard AC, Carcopino X, et al. Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2/3) in France: EDITH study. Int J Cancer. 2008;122(2):424-427 (Pubitemid 350234731)
26. Wheeler CM, Hunt WC, Schiffman M, Castle PE; Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis. 2006;194(9):1291-1299
27. Harper DM, Franco EL, Wheeler CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006;367(9518):1247-1255